Inflammatory breast cancer (IBC) is a lethal malignancy. Recent advances in systemic therapies have significantly improved survival rates for patients with this aggressive form of breast cancer.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: